BARIUM SULFATE

BARIUM SULFATE was reported 438 times

BARIUM SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BARIUM IMPACTION 7 0.4118
1 ATRIO-OESOPHAGEAL FISTULA 1 0.0769
2 BARIUM SWALLOW ABNORMAL 1 0.0455
3 BRONCHIAL ANASTOMOSIS COMPLICATION 1 0.0417
4 PLATYPNOEA 1 0.0345
5 THYROID STIMULATING IMMUNOGLOBULIN 1 0.0323
6 ILEOCOLECTOMY 2 0.0200
7 VASCULAR ACCESS MALFUNCTION 1 0.0185
8 CATHETER SITE GRANULOMA 1 0.0175
9 BLOOD TESTOSTERONE FREE INCREASED 1 0.0167
10 RENOVASCULAR HYPERTENSION 1 0.0125
11 MICROCOCCUS INFECTION 1 0.0123
12 UMBILICAL DISCHARGE 1 0.0116
13 MANUFACTURING PRODUCTION ISSUE 1 0.0096
14 CARCINOID TUMOUR OF THE SMALL BOWEL 1 0.0096
15 PULMONARY VEIN STENOSIS 1 0.0085
16 FAECALITH 1 0.0083
17 POSTOPERATIVE RENAL FAILURE 1 0.0069
18 UMBILICAL HAEMORRHAGE 1 0.0066
19 PERINEPHRIC ABSCESS 1 0.0066
20 ASPIRATION 69 0.0063
21 LUMBOSACRAL RADICULOPATHY 1 0.0062
22 VASCULAR ACCESS SITE HAEMORRHAGE 1 0.0062
23 BLADDER CYST 1 0.0062
24 TRI-IODOTHYRONINE FREE INCREASED 1 0.0058
25 OESOPHAGEAL NEOPLASM 1 0.0054
26 DEAFNESS PERMANENT 1 0.0051
27 METASTASES TO ABDOMINAL WALL 1 0.0050
28 UTERINE INFLAMMATION 1 0.0046
29 FAMILIAL PERIODIC PARALYSIS 1 0.0044
30 RADIOISOTOPE SCAN ABNORMAL 3 0.0042
31 ENTEROBACTER TEST POSITIVE 1 0.0041
32 CHOLANGITIS INFECTIVE 1 0.0038
33 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
34 ASPERGILLUS TEST POSITIVE 1 0.0032
35 WOUND INFECTION PSEUDOMONAS 1 0.0032
36 SALPINGITIS 1 0.0031
37 PNEUMONITIS ASPIRATION 1 0.0029
38 CERVICAL CORD COMPRESSION 1 0.0028
39 FOREIGN BODY IN GASTROINTESTINAL TRACT 1 0.0027
40 CHEMICAL POISONING 1 0.0027
41 TRI-IODOTHYRONINE INCREASED 1 0.0025
42 GRANULOCYTE COUNT INCREASED 1 0.0025
43 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
44 MEDICAL INDUCTION OF COMA 1 0.0024
45 REFLUX LARYNGITIS 1 0.0023
46 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
47 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
48 BILIARY SEPSIS 1 0.0022
49 CONTRAST MEDIA REACTION 5 0.0021
50 TYPE V HYPERLIPIDAEMIA 1 0.0021
51 BREAST CONSERVING SURGERY 1 0.0020
52 KELOID SCAR 1 0.0019
53 PRODUCT DEPOSIT 3 0.0019
54 BRAIN MIDLINE SHIFT 1 0.0019
55 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
56 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
57 IRIS DISORDER 1 0.0019
58 RECTAL PERFORATION 1 0.0019
59 BRONCHOSTENOSIS 1 0.0018
60 GROIN INFECTION 1 0.0018
61 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 1 0.0017
62 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
63 PSOAS ABSCESS 1 0.0016
64 THYROXINE FREE INCREASED 1 0.0016
65 AUTOIMMUNE COLITIS 1 0.0016
66 PROCEDURAL ANXIETY 1 0.0015
67 INFECTIOUS PERITONITIS 1 0.0015
68 SCROTAL OEDEMA 1 0.0014
69 FOREIGN BODY ASPIRATION 1 0.0014
70 DIFFERENTIATION SYNDROME 1 0.0014
71 CHOLANGIOCARCINOMA 2 0.0013
72 MYOPERICARDITIS 1 0.0013
73 IMPLANT SITE EXTRAVASATION 1 0.0013
74 LIP ERYTHEMA 1 0.0013
75 DENTAL DISCOMFORT 1 0.0012
76 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
77 APTYALISM 1 0.0012
78 PSEUDOMONAL BACTERAEMIA 1 0.0012
79 PRODUCT COLOUR ISSUE 6 0.0012
80 ENDOCRINE OPHTHALMOPATHY 1 0.0012
81 PERIPHERAL NERVE INJURY 1 0.0011
82 CATHETER SITE PRURITUS 1 0.0011
83 BLOOD ALBUMIN INCREASED 1 0.0011
84 MUCOSAL EROSION 1 0.0011
85 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
86 NEPHROGENIC ANAEMIA 5 0.0011
87 INTUSSUSCEPTION 1 0.0010
88 COLON ADENOMA 1 0.0010
89 ULNA FRACTURE 1 0.0010
90 STRESS URINARY INCONTINENCE 1 0.0009
91 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
92 CARBON DIOXIDE DECREASED 1 0.0009
93 MACROCYTOSIS 1 0.0009
94 PAROTITIS 1 0.0009
95 GROIN ABSCESS 1 0.0008
96 ACUTE LUNG INJURY 1 0.0008
97 PNEUMONIA INFLUENZAL 1 0.0008
98 RECTAL PROLAPSE 1 0.0008
99 LIP DISCOLOURATION 1 0.0008
100 SEROMA 1 0.0008
101 BRONCHIAL SECRETION RETENTION 1 0.0008
102 LIP INJURY 1 0.0008
103 LIP EXFOLIATION 1 0.0008
104 TONGUE DRY 1 0.0007
105 CLUSTER HEADACHE 1 0.0007
106 BEZOAR 1 0.0007
107 INCISIONAL HERNIA 1 0.0007
108 PERIODONTAL DISEASE 1 0.0007
109 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
110 PERIPHERAL ARTERY OCCLUSION 1 0.0007
111 CHORIORETINOPATHY 1 0.0007
112 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
113 HYPOAESTHESIA FACIAL 1 0.0007
114 MEAN CELL VOLUME DECREASED 1 0.0006
115 INTERMITTENT CLAUDICATION 1 0.0006
116 COSTOCHONDRITIS 1 0.0006
117 TROPONIN I INCREASED 1 0.0006
118 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
119 BLOOD PH DECREASED 1 0.0006
120 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
121 PSEUDOMONAL SEPSIS 1 0.0006
122 TRANSPLANT DYSFUNCTION 1 0.0006
123 TETANY 1 0.0005
124 ESSENTIAL HYPERTENSION 1 0.0005
125 CONTRAST MEDIA ALLERGY 1 0.0005
126 PNEUMONIA KLEBSIELLA 1 0.0005
127 BLOOD CHOLESTEROL DECREASED 1 0.0005
128 BILE DUCT OBSTRUCTION 1 0.0005
129 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
130 LARGE INTESTINAL STENOSIS 1 0.0005
131 EXTRAVASATION 2 0.0005
132 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
133 PHARYNGEAL ERYTHEMA 1 0.0005
134 HYPERPHOSPHATAEMIA 1 0.0005
135 EXOPHTHALMOS 1 0.0005
136 TONGUE BLISTERING 1 0.0004
137 SMALL INTESTINE CARCINOMA 1 0.0004
138 CHRONIC GASTRITIS 1 0.0004
139 EOSINOPHIL COUNT DECREASED 1 0.0004
140 HYPERPARATHYROIDISM SECONDARY 1 0.0004
141 CATHETER SITE PAIN 1 0.0004
142 COMPARTMENT SYNDROME 1 0.0004
143 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
144 ADVERSE REACTION 5 0.0004
145 PROTEIN TOTAL INCREASED 1 0.0004
146 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
147 ABDOMINAL MASS 1 0.0004
148 SHOULDER ARTHROPLASTY 1 0.0004
149 SKIN WRINKLING 1 0.0004
150 LIP BLISTER 1 0.0004
151 CLUMSINESS 1 0.0004
152 PANCREATIC CARCINOMA METASTATIC 1 0.0004
153 PRODUCT LABEL CONFUSION 2 0.0003
154 CEREBROVASCULAR DISORDER 1 0.0003
155 REBOUND ACID HYPERSECRETION 1 0.0003
156 END STAGE RENAL DISEASE 6 0.0003
157 DUODENITIS 1 0.0003
158 APPENDICITIS 3 0.0003
159 BLADDER PAIN 1 0.0003
160 ORTHOPNOEA 1 0.0003
161 PORTAL VEIN THROMBOSIS 1 0.0003
162 LIVER ABSCESS 1 0.0003
163 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
164 POSTURE ABNORMAL 1 0.0003
165 REGURGITATION 1 0.0003
166 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
167 EAR PRURITUS 1 0.0003
168 MONOCYTE COUNT INCREASED 1 0.0003
169 GASTROINTESTINAL PAIN 3 0.0003
170 AMYLASE INCREASED 1 0.0003
171 LIPASE INCREASED 2 0.0003
172 THYROID MASS 1 0.0003
173 CONCUSSION 2 0.0003
174 POLYDIPSIA 1 0.0003
175 ARTERIOSPASM CORONARY 1 0.0002
176 INTRACRANIAL ANEURYSM 1 0.0002
177 TRIGEMINAL NEURALGIA 1 0.0002
178 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
179 POLYURIA 2 0.0002
180 EMBOLISM 2 0.0002
181 GASTROINTESTINAL PERFORATION 1 0.0002
182 HAEMODIALYSIS 2 0.0002
183 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
184 PURULENT DISCHARGE 1 0.0002
185 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
186 TONGUE DISCOLOURATION 1 0.0002
187 PHYSICAL DISABILITY 1 0.0002
188 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
189 WRONG DRUG ADMINISTERED 2 0.0002
190 SNEEZING 5 0.0002
191 ANAL INCONTINENCE 2 0.0002
192 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
193 LOCALISED OEDEMA 1 0.0002
194 HEPATIC ENCEPHALOPATHY 2 0.0002
195 SKIN ABRASION 1 0.0002
196 EXPIRED PRODUCT ADMINISTERED 7 0.0002
197 MEDICATION RESIDUE PRESENT 1 0.0002
198 HUMERUS FRACTURE 1 0.0002
199 GUILLAIN-BARRE SYNDROME 1 0.0002
200 DIZZINESS POSTURAL 2 0.0002
201 RENAL TUBULAR NECROSIS 2 0.0002
202 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
203 RESPIRATORY DISORDER 6 0.0002
204 PNEUMONIA ASPIRATION 5 0.0002
205 DERMATITIS EXFOLIATIVE 1 0.0002
206 TOXIC SKIN ERUPTION 2 0.0002
207 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
208 ECONOMIC PROBLEM 3 0.0002
209 CHRONIC KIDNEY DISEASE 15 0.0002
210 FEMORAL NECK FRACTURE 1 0.0002
211 STOMACH DISCOMFORT 1 0.0002
212 NO ADVERSE EVENT 35 0.0002
213 LUNG INFECTION 3 0.0002
214 FOOD CRAVING 1 0.0002
215 PHARYNGOLARYNGEAL PAIN 1 0.0002
216 FAECALOMA 1 0.0002
217 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
218 MOUTH SWELLING 1 0.0002
219 HYPERVENTILATION 1 0.0002
220 LOCAL SWELLING 3 0.0002
221 SKIN WARM 1 0.0002
222 CAESAREAN SECTION 2 0.0002
223 SPLENOMEGALY 2 0.0002
224 PROTHROMBIN TIME PROLONGED 1 0.0002
225 URTICARIA 28 0.0002
226 SPINAL OPERATION 2 0.0002
227 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
228 INFUSION SITE EXTRAVASATION 1 0.0002
229 MULTIPLE INJURIES 1 0.0002
230 POOR QUALITY DRUG ADMINISTERED 1 0.0002
231 INCOHERENT 1 0.0002
232 PRODUCT PREPARATION ISSUE 1 0.0002
233 PRODUCT FORMULATION ISSUE 1 0.0002
234 APPETITE DISORDER 1 0.0002
235 CARDIAC FAILURE ACUTE 1 0.0001
236 POST-TRAUMATIC STRESS DISORDER 1 0.0001
237 PRODUCT PHYSICAL ISSUE 3 0.0001
238 METASTASES TO LYMPH NODES 1 0.0001
239 TACHYPNOEA 2 0.0001
240 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
241 IMPAIRED GASTRIC EMPTYING 2 0.0001
242 ABNORMAL LOSS OF WEIGHT 1 0.0001
243 RESPIRATION ABNORMAL 1 0.0001
244 DROOLING 1 0.0001
245 LARGE INTESTINE PERFORATION 1 0.0001
246 DEFAECATION URGENCY 1 0.0001
247 HYPOXIA 5 0.0001
248 PAPULE 1 0.0001
249 BLINDNESS UNILATERAL 2 0.0001
250 DUODENAL ULCER 1 0.0001
251 HYPERGLYCAEMIA 5 0.0001
252 GASTROENTERITIS 2 0.0001
253 RENAL FAILURE 18 0.0001
254 RENAL INJURY 4 0.0001
255 HYDRONEPHROSIS 1 0.0001
256 BREAST TENDERNESS 1 0.0001
257 HEPATIC FAILURE 4 0.0001
258 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
259 TROPONIN INCREASED 1 0.0001
260 AORTIC ANEURYSM 1 0.0001
261 BOWEL MOVEMENT IRREGULARITY 1 0.0001
262 PROCEDURAL COMPLICATION 1 0.0001
263 PHARYNGEAL OEDEMA 2 0.0001
264 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
265 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
266 PULMONARY HAEMORRHAGE 1 0.0001
267 PNEUMOTHORAX 2 0.0001
268 TRANSPLANT REJECTION 1 0.0001
269 ENCEPHALOPATHY 3 0.0001
270 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
271 VENTRICULAR TACHYCARDIA 2 0.0001
272 ACUTE KIDNEY INJURY 18 0.0001
273 CIRCULATORY COLLAPSE 2 0.0001
274 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
275 PRODUCT CONTAINER ISSUE 1 0.0001
276 MULTI-ORGAN FAILURE 2 0.0001
277 PYELONEPHRITIS 1 0.0001
278 ANHEDONIA 3 0.0001
279 ANGIOEDEMA 5 0.0001
280 RESPIRATORY RATE INCREASED 1 0.0001
281 FACIAL PAIN 1 0.0001
282 THIRST 2 0.0001
283 MYOSITIS 1 0.0001
284 PNEUMONITIS 3 0.0001
285 GASTROINTESTINAL CARCINOMA 1 0.0001
286 ANAPHYLACTIC REACTION 6 0.0001
287 CONJUNCTIVITIS 2 0.0001
288 NEPHROPATHY 1 0.0001
289 DEFORMITY 1 0.0001
290 DIARRHOEA HAEMORRHAGIC 1 0.0001
291 FLANK PAIN 1 0.0001
292 INTESTINAL OBSTRUCTION 4 0.0001
293 HYPOCALCAEMIA 2 0.0001
294 ABDOMINAL DISTENSION 11 0.0001
295 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
296 ACUTE RESPIRATORY FAILURE 2 0.0001
297 ATELECTASIS 1 0.0001
298 HAEMORRHOIDS 2 0.0001
299 COELIAC DISEASE 1 0.0001
300 BRAIN INJURY 1 0.0001
301 CYTOKINE RELEASE SYNDROME 2 0.0001
302 PLEURAL EFFUSION 6 0.0001
303 SUBARACHNOID HAEMORRHAGE 1 0.0001
304 SLUGGISHNESS 1 0.0001
305 EAR DISCOMFORT 1 0.0001
306 TEMPERATURE INTOLERANCE 1 0.0001
307 HYPERBILIRUBINAEMIA 1 0.0001
308 VENTRICULAR EXTRASYSTOLES 1 0.0001
309 SWOLLEN TONGUE 3 0.0001
310 PRODUCT ODOUR ABNORMAL 1 0.0001
311 INCONTINENCE 1 0.0001
312 PRURITUS GENERALISED 2 0.0001
313 BIPOLAR DISORDER 1 0.0001
314 SKIN LACERATION 1 0.0001
315 OESOPHAGITIS 1 0.0001
316 DENTAL CARIES 1 0.0001
317 VENTRICULAR FIBRILLATION 1 0.0001
318 HYPERTENSIVE CRISIS 1 0.0001
319 MALNUTRITION 1 0.0001
320 TYPE 2 DIABETES MELLITUS 3 0.0001
321 INTESTINAL PERFORATION 1 0.0001
322 FISTULA 1 0.0001
323 MITRAL VALVE INCOMPETENCE 1 0.0001
324 MICTURITION URGENCY 1 0.0001
325 HYPERKALAEMIA 3 0.0001
326 SEXUAL DYSFUNCTION 1 0.0001
327 BACTERAEMIA 1 0.0001
328 CHOLECYSTITIS 1 0.0001
329 NO THERAPEUTIC RESPONSE 1 0.0001
330 RESPIRATORY DEPRESSION 1 0.0001
331 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
332 GENERALISED OEDEMA 1 0.0001
333 HAIR COLOUR CHANGES 1 0.0001
334 BRAIN OEDEMA 1 0.0001
335 COLITIS 3 0.0001
336 GASTRIC CANCER 2 0.0001
337 HAEMATOMA 2 0.0001
338 INJECTION SITE INDURATION 1 0.0001
339 BLOOD CREATININE INCREASED 5 0.0001
340 PULMONARY CONGESTION 1 0.0001
341 SARS-COV-2 TEST POSITIVE 1 0.0001
342 FREQUENT BOWEL MOVEMENTS 2 0.0001
343 SINUS CONGESTION 1 0.0001
344 AKATHISIA 1 0.0001
345 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
346 POLLAKIURIA 3 0.0001
347 FEELING COLD 2 0.0001
348 HYPOMAGNESAEMIA 1 0.0001
349 BURNING SENSATION 5 0.0001
350 OXYGEN SATURATION DECREASED 4 0.0001
351 DEVICE OCCLUSION 1 0.0001
352 TARDIVE DYSKINESIA 2 0.0001
353 DIALYSIS 1 0.0001
354 SINUS TACHYCARDIA 1 0.0001
355 SUBDURAL HAEMATOMA 1 0.0001
356 PARAESTHESIA ORAL 1 0.0001
357 HYPERTHYROIDISM 1 0.0001
358 HYPOKINESIA 1 0.0001
359 FLUID OVERLOAD 1 0.0001
360 NASAL CONGESTION 4 0.0001
361 ASCITES 2 0.0001
362 URINARY INCONTINENCE 2 0.0001
363 PULMONARY OEDEMA 3 0.0001
364 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
365 THROAT IRRITATION 3 0.0001
366 APHASIA 2 0.0001
367 LACRIMATION INCREASED 2 0.0001
368 FEELING HOT 4 0.0001
369 OCULAR HYPERAEMIA 3 0.0001
370 HALLUCINATION, AUDITORY 1 0.0001
371 OBESITY 1 0.0001
372 RASH ERYTHEMATOUS 3 0.0001
373 HIP FRACTURE 2 0.0001
374 SWELLING FACE 4 0.0001
375 METASTASES TO BONE 1 0.0001
376 PHOTOSENSITIVITY REACTION 1 0.0001
377 FEBRILE NEUTROPENIA 4 0.0001
378 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
379 LIP SWELLING 2 0.0001
380 COAGULOPATHY 1 0.0001
381 PERICARDITIS 1 0.0001
382 INFLAMMATION 3 0.0001
383 HEAD DISCOMFORT 1 0.0001
384 ABDOMINAL PAIN 13 0.0001
385 RASH PRURITIC 3 0.0001
386 LEUKOCYTOSIS 1 0.0001
387 BONE DISORDER 1 0.0001
388 HYPERSENSITIVITY 10 0.0001
389 HEPATIC STEATOSIS 1 0.0001
390 NECK PAIN 3 0.0001
391 EPISTAXIS 4 0.0001
392 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
393 PHOTOPHOBIA 1 0.0001
394 FLATULENCE 3 0.0001
395 BLOOD URINE PRESENT 1 0.0001
396 DEHYDRATION 7 0.0001
397 CONVULSION 3 0.0001
398 SLEEP APNOEA SYNDROME 1 0.0001
399 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
400 POST PROCEDURAL COMPLICATION 1 0.0001
401 GLAUCOMA 1 0.0001
402 HERNIA 1 0.0001
403 ERUCTATION 1 0.0001
404 EAR PAIN 1 0.0001
405 ATRIAL FIBRILLATION 5 0.0001
406 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
407 CHOKING 1 0.0001
408 KIDNEY INFECTION 1 0.0001
409 DISABILITY 1 0.0001
410 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
411 DISORIENTATION 2 0.0001
412 HAEMATOCRIT DECREASED 1 0.0001
413 UPPER LIMB FRACTURE 1 0.0001
414 PREGNANCY 1 0.0000
415 COUGH 14 0.0000
416 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
417 PRODUCT ADMINISTRATION ERROR 1 0.0000
418 STOMATITIS 3 0.0000
419 PRURITUS 19 0.0000
420 NEUTROPHIL COUNT DECREASED 2 0.0000
421 PRODUCT PREPARATION ERROR 1 0.0000
422 OSTEOPOROSIS 2 0.0000
423 RIB FRACTURE 1 0.0000
424 CARDIAC ARREST 4 0.0000
425 PERITONITIS 1 0.0000
426 TOOTH LOSS 1 0.0000
427 PULMONARY HYPERTENSION 1 0.0000
428 CARDIO-RESPIRATORY ARREST 2 0.0000
429 MOUTH ULCERATION 1 0.0000
430 HALLUCINATION, VISUAL 1 0.0000
431 RENAL FAILURE ACUTE 2 0.0000
432 RETCHING 1 0.0000
433 HYPERHIDROSIS 6 0.0000
434 POOR QUALITY SLEEP 1 0.0000
435 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
436 FAECES DISCOLOURED 1 0.0000
437 SEPTIC SHOCK 2 0.0000
438 PRODUCT DISPENSING ERROR 1 0.0000
439 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
440 MELAENA 1 0.0000
441 TACHYCARDIA 4 0.0000
442 STEVENS-JOHNSON SYNDROME 1 0.0000
443 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
444 NEPHROLITHIASIS 2 0.0000
445 TINNITUS 2 0.0000
446 SHOCK 1 0.0000
447 HYPOKALAEMIA 2 0.0000
448 OROPHARYNGEAL PAIN 4 0.0000
449 CHILLS 5 0.0000
450 RENAL CANCER 2 0.0000
451 PRODUCT PRESCRIBING ERROR 1 0.0000
452 DIARRHOEA 27 0.0000
453 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
454 LOCALISED INFECTION 1 0.0000
455 MENTAL IMPAIRMENT 1 0.0000
456 NEURALGIA 1 0.0000
457 ABASIA 1 0.0000
458 DYSGEUSIA 3 0.0000
459 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
460 SYNCOPE 4 0.0000
461 HOT FLUSH 3 0.0000
462 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
463 CARDIOVASCULAR DISORDER 1 0.0000
464 HYPOPHAGIA 1 0.0000
465 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
466 ILLNESS 4 0.0000
467 UNRESPONSIVE TO STIMULI 1 0.0000
468 RASH GENERALISED 1 0.0000
469 DIPLOPIA 1 0.0000
470 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
471 SEDATION 1 0.0000
472 MUSCULOSKELETAL PAIN 2 0.0000
473 SPEECH DISORDER 2 0.0000
474 JOINT STIFFNESS 1 0.0000
475 GASTRITIS 1 0.0000
476 PANCREATITIS 2 0.0000
477 BRADYCARDIA 2 0.0000
478 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
479 CARDIAC FAILURE CONGESTIVE 3 0.0000
480 JAUNDICE 1 0.0000
481 CONSTIPATION 8 0.0000
482 MOOD ALTERED 1 0.0000
483 RESPIRATORY ARREST 1 0.0000
484 VOMITING 17 0.0000
485 HAEMOPTYSIS 1 0.0000
486 ABDOMINAL DISCOMFORT 6 0.0000
487 BLISTER 2 0.0000
488 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
489 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
490 INTENTIONAL DOSE OMISSION 1 0.0000
491 RED BLOOD CELL COUNT DECREASED 1 0.0000
492 HYPOTENSION 7 0.0000
493 HYPERSOMNIA 1 0.0000
494 LETHARGY 2 0.0000
495 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
496 RASH 15 0.0000
497 MUSCULOSKELETAL STIFFNESS 3 0.0000
498 ABDOMINAL PAIN UPPER 7 0.0000
499 ACUTE MYOCARDIAL INFARCTION 1 0.0000
500 CATARACT 2 0.0000
501 BLOOD POTASSIUM DECREASED 1 0.0000
502 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
503 SWELLING 3 0.0000
504 DYSPNOEA 18 0.0000
505 PYREXIA 11 0.0000
506 DYSPHAGIA 3 0.0000
507 CYSTITIS 1 0.0000
508 HYPOTHYROIDISM 1 0.0000
509 METABOLIC ACIDOSIS 1 0.0000
510 NIGHT SWEATS 1 0.0000
511 IMPAIRED HEALING 1 0.0000
512 OSTEONECROSIS 1 0.0000
513 STAPHYLOCOCCAL INFECTION 1 0.0000
514 DECREASED APPETITE 7 0.0000
515 VISUAL ACUITY REDUCED 1 0.0000
516 URINARY RETENTION 1 0.0000
517 FLUSHING 3 0.0000
518 PRODUCT QUALITY ISSUE 4 0.0000
519 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
520 CHEST DISCOMFORT 3 0.0000
521 ASTHENIA 11 0.0000
522 HAEMATURIA 1 0.0000
523 ERYTHEMA 6 0.0000
524 NIGHTMARE 1 0.0000
525 DELIRIUM 1 0.0000
526 HEART RATE DECREASED 1 0.0000
527 INJURY 2 0.0000
528 HYPERTENSION 6 0.0000
529 LYMPHADENOPATHY 1 0.0000
530 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
531 ANXIETY 8 0.0000
532 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
533 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
534 RESPIRATORY FAILURE 2 0.0000
535 RESTLESSNESS 1 0.0000
536 SEPSIS 3 0.0000
537 EYE SWELLING 1 0.0000
538 PERIPHERAL SWELLING 4 0.0000
539 BACK PAIN 6 0.0000
540 PALPITATIONS 3 0.0000
541 DISEASE PROGRESSION 3 0.0000
542 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
543 DRUG INTERACTION 4 0.0000
544 WEIGHT DECREASED 7 0.0000
545 CARDIAC FAILURE 2 0.0000
546 EMOTIONAL DISTRESS 3 0.0000
547 PNEUMONIA 8 0.0000
548 DYSKINESIA 1 0.0000
549 TREMOR 4 0.0000
550 MYALGIA 4 0.0000
551 URINARY TRACT INFECTION 4 0.0000
552 LOSS OF CONSCIOUSNESS 3 0.0000
553 RECTAL HAEMORRHAGE 1 0.0000
554 HYPOACUSIS 1 0.0000
555 VAGINAL HAEMORRHAGE 1 0.0000
556 PRODUCT STORAGE ERROR 2 0.0000
557 COLITIS ULCERATIVE 1 0.0000
558 MEMORY IMPAIRMENT 3 0.0000
559 MUSCLE SPASMS 4 0.0000
560 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
561 RENAL DISORDER 1 0.0000
562 ARRHYTHMIA 1 0.0000
563 PULMONARY EMBOLISM 2 0.0000
564 FALL 7 0.0000
565 ANAEMIA 4 0.0000
566 MIGRAINE 2 0.0000
567 CONTUSION 2 0.0000
568 INFECTION 3 0.0000
569 LUNG DISORDER 1 0.0000
570 DRY EYE 1 0.0000
571 LEUKOPENIA 1 0.0000
572 FLUID RETENTION 1 0.0000
573 SINUSITIS 2 0.0000
574 NERVOUSNESS 1 0.0000
575 ECZEMA 1 0.0000
576 PARAESTHESIA 3 0.0000
577 DEPRESSED MOOD 1 0.0000
578 PLATELET COUNT DECREASED 2 0.0000
579 DRUG EFFECT DECREASED 1 0.0000
580 TREATMENT NONCOMPLIANCE 1 0.0000
581 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
582 DIZZINESS 9 0.0000
583 MEDICATION ERROR 1 0.0000
584 PAIN 11 0.0000
585 PANCYTOPENIA 1 0.0000
586 EYE PAIN 1 0.0000
587 NAUSEA 14 0.0000
588 MUSCULAR WEAKNESS 2 0.0000
589 DEPRESSION 4 0.0000
590 HERPES ZOSTER 1 0.0000
591 EYE IRRITATION 1 0.0000
592 SEIZURE 2 0.0000
593 DYSPHONIA 1 0.0000
594 BONE PAIN 1 0.0000
595 WHEEZING 1 0.0000
596 FEELING ABNORMAL 4 0.0000
597 VERTIGO 1 0.0000
598 DISCOMFORT 1 0.0000
599 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
600 CHEST PAIN 3 0.0000
601 EXPOSURE DURING PREGNANCY 1 0.0000
602 HEADACHE 10 0.0000
603 RHINORRHOEA 1 0.0000
604 FATIGUE 12 0.0000
605 AMNESIA 1 0.0000
606 BLOOD PRESSURE DECREASED 1 0.0000
607 INSOMNIA 4 0.0000
608 DRY SKIN 2 0.0000
609 NEOPLASM MALIGNANT 1 0.0000
610 SOMNOLENCE 3 0.0000
611 OFF LABEL USE 13 0.0000
612 HEPATIC ENZYME INCREASED 1 0.0000
613 VISION BLURRED 2 0.0000
614 INJECTION SITE SWELLING 1 0.0000
615 THROMBOSIS 1 0.0000
616 CONFUSIONAL STATE 2 0.0000
617 INFLUENZA LIKE ILLNESS 1 0.0000
618 DRUG DOSE OMISSION 2 0.0000
619 ARTHRALGIA 5 0.0000
620 DRUG ABUSE 1 0.0000
621 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
622 CEREBROVASCULAR ACCIDENT 2 0.0000
623 BALANCE DISORDER 1 0.0000
624 INTENTIONAL PRODUCT MISUSE 1 0.0000
625 MALAISE 5 0.0000
626 COVID-19 2 0.0000
627 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
628 GASTROINTESTINAL DISORDER 1 0.0000
629 ADVERSE DRUG REACTION 1 0.0000
630 NASOPHARYNGITIS 2 0.0000
631 BLOOD GLUCOSE INCREASED 2 0.0000
632 GAIT DISTURBANCE 2 0.0000
633 ALOPECIA 2 0.0000
634 PAIN IN EXTREMITY 3 0.0000
635 DYSPEPSIA 1 0.0000
636 HAEMOGLOBIN DECREASED 1 0.0000
637 HAEMORRHAGE 1 0.0000
638 INFLUENZA 1 0.0000
639 THROMBOCYTOPENIA 1 0.0000
640 WEIGHT INCREASED 2 0.0000
641 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
642 JOINT SWELLING 1 0.0000
643 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
644 VISUAL IMPAIRMENT 1 0.0000
645 DRUG INEFFECTIVE 10 0.0000
646 HYPOAESTHESIA 1 0.0000
647 BLOOD PRESSURE INCREASED 1 0.0000
648 HOSPITALISATION 1 0.0000
649 DEATH 5 0.0000
650 MYOCARDIAL INFARCTION 1 0.0000
651 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
652 INCORRECT DOSE ADMINISTERED 1 0.0000
653 PRODUCT DOSE OMISSION ISSUE 1 0.0000
654 CONDITION AGGRAVATED 1 0.0000
655 INJECTION SITE PAIN 1 0.0000